Jia-Horng Kao

114PUBLICATIONS
192CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedOptical technologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (114)

|Aug 08, 2026
HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

|Jul 06, 2026
Artificial Intelligence-Assisted Screening for Patients With Diabetic Retinopathy and Age-Related Macular Degeneration in Family Medicine and Geriatric and Gerontology Care: Protocol for a Pragmatic Randomized Clinical Trial.

|Feb 27, 2026
Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification.

Tai-Chung Tseng, Shang-Chin Huang, Jia-Horng Kao

|Jan 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng

|Jan 06, 2026
IgG4-Associated Autoimmune Hepatitis: a Systematic Review.

Chun-Hsun Liao, Hsu-Hua Tseng, Ting-An Shen

|Nov 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee

Pageof 19

Frequent Collaborators

29 joint publications

Chen-Hua Liu

21 joint publications

Chun-Jen Liu

20 joint publications

Tung-Hung Su

16 joint publications

Cheng-Yuan Peng